Cost differences between oral anticoagulation therapies in atrial fibrillation patients

30 August 2024 (08:00 - 17:30)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Mr Ossi Lehtonen

University of Eastern Finland, Kuopio (Finland)

4 More presentations in this session

Presentation thumbnail

Disparities by region, age, and sex in cardiovascular disease burden attributable to high fasting plasma glucose in China, 2010-2018: a nationwide, population-based study.

Miss X. Cao (Beijing, CN)

Abstract Slides Video

Presentation thumbnail

Embedding a text message recall system to increase the uptake of cardiovascular screening in Australian general practice. Results of the Text to Detect randomised controlled trial

Miss N. Raffoul (Sydney, AU)

Abstract Slides Video

Presentation thumbnail

Independent associations of educational attainment and its joint associations with LE8 score for risk of cardiovascular disease incidence and mortality among Chinese people

Doctor Z. Chen (Changsha, CN)

Abstract Slides Video

Presentation thumbnail

Cost-effectiveness of semaglutide for secondary prevention of cardiovascular disease in the United States

Doctor S. Hennessy (San Francisco, US)

Abstract Slides Video

Access the full session

Session thumbnail

Disparities: insights into socioeconomic factors and cardiovascular health

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

You may be interested in

Congress Presentation

Real-world evaluation of an algorithmic machine-learning-guided testing approach in stable chest pain: a multinational, multicohort study

Congress Presentation

The cost-effectiveness of a digitally enabled telerehabilitation program delivered nationally to patients in Australia

Congress Presentation

Let’s go digital: implementing cardiac rehabilitation - discussion

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources